Biotech

NIH sees a need for speed in Traverse Biosciences

By GREGORY ZELLER // The National Institutes of Health has welcomed a rising Stony Brook biotech into its competitive Commercialization Accelerator Program. Traverse Biosciences, which is attempting to commercialize novel drug candidates for the treatment of inflammatory diseases affecting animals and humans, has landed one of 80 annual slots in the CAP, a nine-month program hosted by the NIH and the Larta Institute, a California-based networking group promoting international innovation. The NIH CAP – which…


Printing partnership takes Applied DNA global, again

By GREGORY ZELLER // Diversity-driven Stony Brook biotech Applied DNA Sciences has added yet another vertical market to its rapidly expanding collection: laser printers. And not just printers and inks but third parties that use them to tag their products, packaging and supply-chain components, all available through a new “strategic partnership” between Applied DNA and Videojet Technologies. Under the guidance of an all-star business-development team, the biotech – which specializes in can’t-be-copied, can’t-be-broken DNA-based security…


Feds back NYIT professors on RNA-sequencing quest

By GREGORY ZELLER // Diverse disciplines are coming together at NYIT, where a multi-year National Institutes of Health grant is fueling next-level RNA research – and, possibly, opening a new front in the war against cancer. Two New York Institute of Technology faculty members, assistant professors of life sciences and computer sciences, will combine their skills under a three-year, $568,000 Cutting Edge Basic Research award from the NIH’s National Human Genome Research Institute. Their mission:…


Startup sails past $1M, considers second employee

By GREGORY ZELLER // A key e-commerce alliance has pushed an innovative skin-care company past $1 million in revenues – and has the biotech’s only full-time employee thinking expansion, in more ways than one. Kantian Skincare, a 2012 startup and the public face of Huntington-based Kantian Sciences Corp., hurtled past the $1 million plateau in July, according to cofounder and President Jon Klein, on the back of the Neutralyze Anti-Acne Solution, the company’s flagship product….


Re-Nuble targets USDA over ‘organic’ certifications

By GREGORY ZELLER // A “waste-to-value” biotech with Long Island roots is taking its food-for-all message to the people – and is taking on the U.S. Department of Agriculture over critical “organic” certifications. Re-Nuble Inc., which operates out of facilities in Brooklyn and Long Island City but remains a “virtual tenant” of Stony Brook University’s Clean Energy Business Incubator Program, is presenting Wednesday at Food Tank Summit NYC, a celebration and exploration of food and…


Applied DNA enlists with Army’s bio-warfare defenders

By GREGORY ZELLER // Applied DNA Sciences is in the Army now. Already under U.S. Department of Defense contract on a number of different projects, the Stony Brook-based biotech has entered into a new Cooperative Research and Development Agreement with U.S. Army Research, Development and Engineering Command’s Edgewood Chemical Biological Center. Best known as a developer and distributor of in-house botanical-DNA-based security and authentication protocols, Applied DNA is lending its expertise in a slightly different…


Global nod marks major milestone for Applied DNA

By GREGORY ZELLER // An esteemed international certification organization has stamped a ginning company tracking its cotton supplies with the help of Applied DNA Sciences. The Global Organic Textile Standard certification is another feather in the cap of the Stony Brook biotech, which has long banked on cotton and other textile-focused industries as a business-development cornerstone. The certification was awarded to Woolam Gin of Texas, an Applied DNA “ginning partner,” by Netherlands-based Control Union Certifications,…


ALZ: Genetic variants can run, but they can’t hide

The Feinstein Institute for Medical Research is targeting genetic risk factors behind Alzheimer’s disease, the first of many steps toward new potential treatments. Feinstein Institute assistant professor Yun Freudenberg-Hua has been awarded a five-year, $600,000 grant by the National Institutes of Health’s National Institute on Aging, supporting her mission to better understand the genetic causes of a disease that inflicts an estimated 5.5 million Americans. Ultimately, the doctor and her staff hope to develop new…


NYIT: ‘Lethal interactions’ could stop tough cancers

New York Institute of Technology researchers may have found a way to stop cancerous tumors from spreading through the central nervous system. And for some patients suffering from the worst cancers – and the traditionally awful side effects of conventional chemotherapy – help may be on the way. A July issue of the journal Proceedings of the National Academy of Sciences chronicles the work of associate professor Dong Zhang and his team at NYIT’s College…


For Applied DNA, real growth in fertilizer

By GREGORY ZELLER // Applied DNA Sciences, the Stony Brook biotech, has spent 2017 aggressively introducing its DNA-based supply chain, anti-counterfeiting and anti-theft technologies to new industries and markets – and now adds fertilizer, a critical commodity for global farmers, to its growing list. Less than a month after applying its CertainT authentication platform to plastics – specifically, thermoplastic polymer resin – through a multi-year licensing deal with Indian global textile manufacturer GHCL Ltd., Applied…


Concussion-focused Scythian sets market debut

By GREGORY ZELLER // Scythian Biosciences Corp. is going public. The New York City/Toronto-based biotech, led by Great Neck investment banker Jonathan Gilbert on its quest to develop the world’s first pharmaceutical treatment for concussions, will begin trading Aug. 8 on the TSX Venture Exchange, one of Canada’s major stock markets. Projected to open at $8 (Canadian) per share, Scythian Biosciences (ticker symbol “SCYB”) will float upwards of 2.5 million shares – about half of…


Throwing in more towels, and that’s very good

By GREGORY ZELLER // Another week, another significant partnership for Applied DNA Sciences, which continues to make itself at home in the national textiles market. The Stony Brook-based provider of DNA-focused supply chain, anti-counterfeiting and anti-theft technologies has signed a multi-year licensing agreement with Loftex Home LLC, a well-known maker of high-quality towels and other home textiles. The new deal builds upon a prior agreement between Applied DNA and New York City-based Loftex Home, announced…


Award-winning Re-Nuble lays waste to malnutrition

By GREGORY ZELLER // An outer-borough biotech with a Long Island lineage is racing to the head of the organic-fertilizer field. Re-Nuble Inc., founded by scientifically oriented business IT specialist Tinia Pina, has snagged a 2017 American Entrepreneurship Award and the $25,000 interest-free loan that accompanies it – the latest feathers in the cap of a 2015 startup that transforms food waste into fresh produce. The American Entrepreneurship accolades are doled out by the Libra Group,…


PET project brings Applied DNA to India, and the world

By GREGORY ZELLER // Applied DNA Sciences wants to say one word to you. Just one word. Are you listening? Plastics. After checking cotton, leather, European luxury cars, Department of Defense microcircuits and other diverse, often critical verticals off its to-do list, the Stony Brook-based provider of DNA-focused supply chain, anti-counterfeiting and anti-theft technologies has signed a multi-year licensing deal with global textile manufacturer GHCL Ltd., focused specifically on polyethylene terephthalate. Known best by its…


Stock deal, textile team-up top biotech’s big week

By GREGORY ZELLER // It’s been a busy and happy week for Applied DNA Sciences. Just days after trumpeting a new and potentially lucrative research partnership with Texas-based Aloe vera-products manufacturer Lily of the Desert, the Stony Brook-based supply-chain, anti-counterfeiting, anti-theft and product-authentication specialist announced Wednesday a $1.8 million private placement led by company executives and board members and an unnamed “strategic investor.” Also this week, Applied DNA announced a new licensing agreement with Himatsingka…